{"id":98405,"date":"2021-01-08T07:30:10","date_gmt":"2021-01-08T12:30:10","guid":{"rendered":"http:\/\/kendallharmon.net\/?p=98405"},"modified":"2021-01-08T07:48:13","modified_gmt":"2021-01-08T12:48:13","slug":"cnbc-pfizer-vaccine-appears-to-neutralize-a-key-mutation-of-covid-variants-found-in-uk-south-africa","status":"publish","type":"post","link":"https:\/\/kendallharmon.net\/?p=98405","title":{"rendered":"(CNBC) Pfizer vaccine appears to neutralize a key mutation of Covid variants found in UK, South Africa"},"content":{"rendered":"

A coronavirus vaccine developed by Pfizer<\/a> and BioNTech<\/a> appears to be effective against a key mutation in the more infectious variants of the virus discovered in the U.K. and South Africa, according to a study conducted by the U.S. pharmaceutical giant.<\/p>\n

It comes as countries scramble to contain the variants that are significantly more transmissible<\/a>, with public health experts anxious about the potential impact on inoculation efforts.<\/p>\n

\n
<\/div>\n<\/div>\n

The research, published Thursday on preprint server bioRxiv<\/a> and not yet peer-reviewed, suggested the Pfizer-BioNTech vaccine worked to neutralize the so-called N501Y mutation.<\/p>\n

The N501Y mutation has been reported in the more infectious variants. It is altering an amino acid within six key residues in the receptor-binding domain<\/a> \u2014 a key part of the spike protein that the virus uses to gain entry into cells within the body.<\/p>\n

Read it all<\/a>.<\/p>\n

\n

🏥 A new study shows Pfizer-BioNTech's Covid vaccine appears to neutralize a key mutation of two highly contagious variants found in the U.K. & South Africa.<\/p>\n

🗣️ \u201cThese findings are good news."<\/p>\n

👇 Here's the full story:https:\/\/t.co\/qvANvM2Mk0<\/a><\/p>\n

— Sam Meredith (@smeredith19) January 8, 2021<\/a><\/p><\/blockquote>\n